New opportunities in diabetes mellitus management with Flash glucose monitoring

• Natalya A. Chernikova

Abstract

The growing number of patients with diabetes calls for innovative approaches, including new digital technologies, to ensure glycemic control. It also applies to continuous glucose monitoring. Flash glucose monitoring allows to observe changes in glucose levels immediately, identify trends and patterns of these changes, and make more clear therapeutic decisions with a personalized approach to patient care. A unified digital ecosystem consisting of the LibreView cloud platform, smartphone apps FreeStyle LibreLink and LibreLinkUp has been developed for Flash glucose monitoring. This digital ecosystem provides online access for doctors and patients to the glycemic profile data and additional patient support from their relatives or medical attendants.

This article analyses the outpatient glycemic profile report of a patient with diabetes mellitus using a new report form.

Keywords:diabetes mellitus, continuous glucose monitoring, Flash glucose monitoring, hidden issues, clinical guidelines, hypoglycemia, hyperglycemia, decreasing in number of acute diabetes complications

REFERENCES

1. IDF Diabetes Atlas. 9^th edition, 2019 [Electronic resource]. 2019. URL: https://www.diabetesatlas.org/en/ (accessed: 14.10.2020).

2. Danne T., et al. International consensus on use of continuous glucose monitoring. Diabetes Care. 2017; 40 (12): 1631-40.

3. American Diabetes Association. 6. Glycemic targets: Standards of medical care in diabetes-2021. Diabetes Care. 2021; 44 (Suppl 1): S 7384. DOI: https://doi.org/10.2337/dc21-S006

4. Rayman G. Glycaemic control, glucose variability and the triangle of diabetes care. Br J Diabetes Vasc Dis. 2016; 16: S 3-6.

5. Chernikova N.A. Evolution of continuous glucose monitoring in existing clinical guidelines for patient with diabetes mellitus. Endokrinologiya: novosti, mneniya, obuchenie [Endocrinology: News, Opinions, Training]. 2020; 9 (4): 59-65. DOI: https://doi.org/10.33029/2304-9529-2020-9-4-59-65 (in Russian)

6. Brownlee M H.I. Glycemic variability: a hemoglobin A1c-inde-pendent risk factor for diabetic complications. JAMA. 2006; 295 (14): 1707-8.

7. Battelino T., Danne T., Bergenstal R.M., Amiel S.A., et al. Clinical targets for continuous glucose monitoring data interpretation: Recommendations from the international consensus on time in range. Diabetes Care. 2019; 42 (8): 1593-603. DOI: https://doi.org/10.2337/dci19-0028

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)